NCT06502847View on ClinicalTrials.gov

The Role of Breastmilk and Serum Exosomes in Neonatal Jaundice Due to ABO Incompatibility

CompletedOBSERVATIONAL
Enrollment

338

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

June 1, 2023

Study Completion Date

June 1, 2023

Conditions
Neonatal Jaundice From Other Specified CausesABO IncompatibilityABO Hemolytic Disease
Interventions
OTHER

Exosome profile study

Neonatal serum and maternal exosome profiles will be studied in all groups.

Trial Locations (1)

34303

University of Health Sciences Istanbul KSS Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Kanuni Sultan Suleyman Training and Research Hospital

OTHER

NCT06502847 - The Role of Breastmilk and Serum Exosomes in Neonatal Jaundice Due to ABO Incompatibility | Biotech Hunter | Biotech Hunter